Geode Capital Management, LLC Dexcom Inc Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 9,178,195 shares of DXCM stock, worth $1.09 Billion. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,178,195

Previous 8,917,255 2.93%

Holding current value

$1.09 Billion

Previous $1.11 Billion 15.04%

% of portfolio

0.12%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $29.8 Million - $36.6 Million	260,940 Added 2.93%	9,178,195 $1.27 Billion
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $14.2 Million - $23.4 Million	188,219 Added 2.16%	8,917,255 $1.11 Billion
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $14.8 Million - $23.6 Million	171,458 Added 2.0%	8,729,036 $814 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $30.9 Million - $36 Million	274,915 Added 3.32%	8,557,578 $1.1 Billion
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $17.8 Million - $21 Million	170,796 Added 2.11%	8,282,663 $962 Million

Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $8.22 Million - $11.9 Million	96,683 Added 1.21%	8,111,867 $917 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $14.7 Million - $18.2 Million	192,962 Added 2.47%	8,015,184 $645 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $402 Million - $785 Million	5,910,597 Added 309.19%	7,822,222 $582 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $4.07 Million - $5.64 Million	43,294 Added 2.32%	1,911,625 $976 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $9.58 Million - $12 Million	73,778 Added 4.11%	1,868,331 $1 Billion
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $4.95 Million - $6.65 Million	46,427 Added 2.66%	1,794,553 $979 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $20.5 Million - $27.3 Million	252,773 Added 16.9%	1,748,126 $744 Million
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $44,260 - $54,674	522 Added 0.03%	1,495,353 $536 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $1.12 Million - $1.5 Million	-14,318 Reduced 0.95%	1,494,831 $551 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $4.53 Million - $5.35 Million	47,388 Added 3.24%	1,509,149 $621 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $15 Million - $25.2 Million	239,457 Added 19.59%	1,461,761 $592 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $4.9 Million - $7.75 Million	102,430 Added 9.15%	1,222,304 $329 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $2.17 Million - $3.39 Million	59,161 Added 5.58%	1,119,874 $245 Million
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $2.18 Million - $2.69 Million	-61,302 Reduced 5.46%	1,060,713 $158 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $428,680 - $599,290	15,398 Added 1.39%	1,122,015 $168 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $1.81 Million - $2.46 Million	64,486 Added 6.19%	1,106,617 $132 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $4.12 Million - $5.71 Million	152,781 Added 17.18%	1,042,131 $125 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $519,350 - $816,726	22,242 Added 2.57%	889,350 $127 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $809,541 - $1.16 Million	46,154 Added 5.62%	867,108 $82.4 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $263,433 - $373,970	20,171 Added 2.52%	820,954 $60.9 Million
Q4 2017 Feb 13, 2018	BUY	$11.12 - $15.38 $93,897 - $129,868	8,444 Added 1.07%	800,783 $46 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $160,380 - $267,959	14,118 Added 1.81%	792,339 $38.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	778,221	778,221 $56.9 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $45.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Dexcom Inc Transaction History